NCT01219478

Brief Summary

Purpose: To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion. Methods: Fifty-two patients over 60 y/o were divided into four groups according to their MRs of hypertension, hyperlipidemia or hyperglyceremia. After complete ophthalmic examination, optical coherence tomography was performed to measure RT.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2009

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2009

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2009

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

October 10, 2010

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 13, 2010

Completed
Last Updated

December 21, 2010

Status Verified

December 1, 2010

First QC Date

October 10, 2010

Last Update Submit

December 19, 2010

Conditions

Visual Acuity

Keywords

To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion

Study Arms (4)

control

0 metabloil risk

1

1 metabloil risk

2

2 metabloil risk

3

3 metabloil risk

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who were over 60 y/o were divided into four groups according to their MRs of hypertension, hyperlipidemia or hyperglyceremia.

You may qualify if:

  • We enrolled the patients included age more than 60 years old, no positive finding during dilated fundus examination.

You may not qualify if:

  • systemic disease that will affect visual acuity evaluation (for example: CVA), \*opaque cornea and vitreous
  • glaucoma
  • uvietis and other clinically established ocular disease.
  • According to the LOCS III11, those who had nuclear opalescence, nuclear color more than grade 3 or any grade of cortical cataract and posterior subcapsular cataract were also eliminated.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Taipei Medical University - WanFang Hospital

Taipei, Taiwan

Location

Study Officials

  • Hui-Chun Ho

    Taipei Medical University WanFang Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

October 10, 2010

First Posted

October 13, 2010

Study Start

January 1, 2009

Study Completion

December 1, 2009

Last Updated

December 21, 2010

Record last verified: 2010-12

Locations

TW(1)